Publicacions en què col·labora amb Estíbaliz Alegre Martínez (11)

2023

  1. PSA reactivity in extracellular microvesicles to commercial immunoassays

    Clinica Chimica Acta, Vol. 543

2021

  1. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients

    Cytokine, Vol. 141

2020

  1. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348

  2. Realización de pruebas innecesarias en los ensayos clínicos: HCG como ejemplo

    Advances in Laboratory Medicine

  3. Unnecessary test ordering in clinical trials: Human chorionic gonadotropin as an example

    Advances in Laboratory Medicine

2019

  1. Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis

    Clinical Chemistry and Laboratory Medicine, Vol. 57, Núm. 10, pp. 1539-1545

  2. The dynamic use of EGFR mutation analysis in cell-free DNA as a follow-up biomarker during different treatment lines in non-small-cell lung cancer patients

    Disease Markers, Vol. 2019

2018

  1. Liquid Biopsy: From Basic Research to Clinical Practice

    Advances in Clinical Chemistry (Academic Press Inc.), pp. 73-119

2016

  1. Circulating melanoma exosomes as diagnostic and prognosis biomarkers

    Clinica Chimica Acta, Vol. 454, pp. 28-32

  2. Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

    Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694

2014

  1. Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients

    Clinica Chimica Acta, Vol. 429, pp. 168-174